Bevacizumab/Doxorubicin/Radiation for Sarcoma

NCT01746238 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Bevacizumab
DRUG: Doxorubicin
RADIATION: Radiation Therapy

Sponsor

Massachusetts General Hospital